Team:SupBiotech-Paris/Concept
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
Line 5: | Line 5: | ||
- | {| class="wikitable" width=" | + | {| class="wikitable" width="400px" align="center" |
|+ Tableau | |+ Tableau | ||
|- | |- | ||
Line 31: | Line 31: | ||
Difficile | Difficile | ||
|- | |- | ||
- | | width=" | + | | width="90px" | |
Phage | Phage | ||
| width="34%" | | | width="34%" | | ||
Line 46: | Line 46: | ||
Facile | Facile | ||
|- | |- | ||
- | | width=" | + | | width="90px" | |
Bactérie | Bactérie | ||
| width="34%" | | | width="34%" | | ||
Line 61: | Line 61: | ||
Facile | Facile | ||
|- | |- | ||
- | | width=" | + | | width="90px" | |
Nanoparticule lipidique | Nanoparticule lipidique | ||
| width="34%" | | | width="34%" | | ||
Line 76: | Line 76: | ||
Moyenne | Moyenne | ||
|- | |- | ||
- | | width=" | + | | width="90px" | |
Nanoparticule polymère | Nanoparticule polymère | ||
| width="34%" | | | width="34%" | |
Revision as of 12:46, 14 October 2009
Type/Problématique | Stabilité | Toxicité | Ciblage | Passage des membranes | Résistance au Syst. Immun. | Industrialisation |
---|---|---|---|---|---|---|
Virus |
Bonne |
Forte |
Cellulaire |
Très Bon |
Nulle |
Difficile |
Phage |
Bonne |
Faible |
Cellulaire |
Faible |
Nulle |
Facile |
Bactérie |
Bonne |
Faible/Forte |
Tissulaire |
Nulle |
Faible/Forte |
Facile |
Nanoparticule lipidique |
Faible |
Faible |
Cellulaire |
Moyen |
Faible |
Moyenne |
Nanoparticule polymère |
Bonne |
Moyenne |
Cellulaire |
Faible |
Faible |
Moyenne |